You are here:   Our PeopleAbhishek K. Gurnani
Abhishek K. Gurnani

Rakesh M. Amin

312.327.3325 Directdirect
abhishek@amintalati.com

 

55 West Monroe Street
Suite 3400
Chicago, IL 60603
312.466.1033 phone
312.884.7352 fax

Practices

Regulatory Practice

Intellectual Property Practice

Litigation Practice

Transactional Practice

  
 

Abhishek Gurnani is a Member at Amin Talati & Upadhye. Mr. Gurnani provides regulatory, transactional and litigation services to food, drug, dietary supplement, medical device, and cosmetic companies.

Mr. Gurnani primarily advises companies on legal and regulatory matters relating to the Food and Drug Administration (FDA), the Federal Trade Commission (FTC), United States Customs, United States Department of Agriculture (USDA) and other federal and state regulatory agencies. Mr. Gurnani regularly assists clients with  drug and medical device listings, food, drug and medical device facility registrations, 510k medical device submissions, new dietary ingredient notifications, FDA detentions, FDA Import Alerts, FDA warning letters and Form 483 observations, FTC, NAD, and State substantiation inquiries, as well as a variety of other regulatory matters involving FDA, FTC, USDA, U.S. Customs and EPA.

Mr. Gurnani previously clerked for the Illinois State Department of Professional Regulation where he assisted Department attorneys with medical and health related prosecutions.

Education

J.D., The John Marshall Law School

B.S., Biomedical Engineering, University of Illinois at Chicago

Bar Admissions

Illinois

Publications

A. Gurnani. “FSMA Gives FDA Emergency Access to Records.”  Natural Products Insider. May/June 2014.

A. Gurnani. “FDA Showcases Mandatory Recall Powers Under FSMA.”  Natural Products Insider. January/February 2014.

A. Talati and A. Gurnani. "FDA Issues Controversial Draft Guidance on New Dietary Ingredients.  Food Drug Law Institute.  Update Magazine.  March/April 2012.

A. Talati and A. Gurnani. "Chapter 8: New Dietary Ingredients." The FDA Food Safety Modernization Act: A Comprehensive, Practical Guide to the Landmark Legislation. Washington, D.C.: Food and Drug Law Institute, 2012. 137-57.

A. Talati and A. Gurnani. "Dietary Supplement Adverse Event Reports: Review and Analysis." Food Drug Law J. 2009;64(3):503-13.

A. Talati and A. Gurnani. "The World's Most Trusted Article on Puffery" : Non-Actionable Puffery or Misleading? Food and Drug Law Institute. Update Magazine. Issue 6 (2008).
 

 

 

  
 
 
The content in the AminTalati web site may constitute attorney advertising or advertising material within the meaning of applicable bar rules, and/or under the Rules of Professional Conduct governing lawyers. Nothing in this site is to be considered as either creating an attorney-client relationship between the reader and AminTalati or as the rendering of legal advice for any specific matter.
Privacy Statement Terms Of Use Site Map
   
 
);